In published research it has been investigated for its effects on tissue repair, angiogenesis, gastrointestinal mucosal protection and anti-inflammatory signalling in animal and cell-culture models
Patients should be reassured that gastrointestinal symptoms often improve with continued therapy as tolerance develops
While the numbers suggest that retatrutide may lead to greater weight loss than currently approved medications, only a head-to-head clinical trial can determine how the drugs truly compare
In medical weight loss, semaglutide may help appropriate patients by supporting fullness after smaller meals, reducing appetite and food noise, improving portion control, supporting blood sugar regulation, helping some patients improve cardiometabolic risk markers, and supporting weight loss when combined with nutrition, activity, and medical monitoring